Abstract
AbstractAntifolates were among the first broad-spectrum compounds used as antimycobacterial agents and can still be of use when no other therapeutic options are available. The discovery of compounds targeting this essential pathway could lead to new therapeutic agents to treat tuberculosis (TB). In particular, the enzyme required for the conversion of 7,8-dihydroneopterin (DHNP) to 6-hydroxymethyl-7,8-dihydropterin (HP) and glycolaldehyde (GA) in the folate pathway (MtbFolB, a dihydroneopterin aldolase - DHNA, EC 4.1.2.25), has received little attention as a potential drug target. Here, we conducted a small-scale diversity screening to identifyMtbFolB inhibitors using a microplate-based enzyme inhibition assay. About 6,000 compounds were assembled for the screening and 19 hits were identified, spanning 5 independent clusters. These compounds were tested in dose-response studies and active compounds selected for kinetic inhibition and time-dependent inhibition studies, leading to compounds with IC50values ranging from 2.6 to 47 µM. A preliminary structure activity analysis was performed, revealing that bi-sulfonamide compounds could be explored for further optimizations. Docking studies highlighted two modes of binding for pyrazol-3-one compounds and, for the sulfonamide series, indicated several interactions with the catalytic Tyrosine-54 (Tyr54D) and Lysine-99 (Lys99A) residues ofMtbFolB. The sulfonamide compound13represents the first identified compound directed againstMtbFolB with an antimycobacterial activity.
Publisher
Cold Spring Harbor Laboratory
Reference25 articles.
1. Henderson, G. and F. Huennekens , [42] Membrane-Associated folate transport proteins, in Methods in enzymology. 1986, Elsevier. p. 260–269.
2. The relation of p-aminobenzoic acid to the mechanism of the action of sulphanilamide;British Journal of Experimental Pathology,1940
3. Pyrimidine derivatives as antagonists of pteroylglutamic acid;Journal of Biological Chemistry,1948
4. Keys, T. Antimicrobials commonly used for urinary tract infection: sulfonamides, trimethoprim-sulfamethoxazole, nitrofurantoin, nalidixic acid. in Mayo Clinic Proceedings. 1977.
5. Sulfone Therapy of Leprosy. Background, Early History and Present Status;International journal of Leprosy,1963